(Bloomberg) --The world’s biggest asset manager is “turning up the risk dial” by doubling down on US equities and artificial intelligence exposure across its $185 billion model-portfolio platform, ...

Upstart's stock has experienced significant volatility since its IPO in 2021. The company utilizes an AI-driven lending model to underwrite consumer credit, resulting in higher approval rates and ...

In our community we’re no strangers to making things, and there are plenty among us who devote their efforts to modelmaking. It’s uncommon, though, for a scale model of something to be made using the ...

According to the official Tesla China website on Wednesday, deliveries for the Model Y L won't take place until November 2025, indicating that the EV giant has run out of Model Y L units for the rest ...

In a rare move, more than three dozen BYD executives increased their stakes in the world’s largest electric-vehicle (EV) maker, which is likely to boost investor confidence after its shares plunged ...

Automakers debut new EVs, affordable models at Munich car show Major automakers showcased their latest models at the Munich car show today, unveiling new EVs and lower-cost models as Europe's car ...

Investment firm Iconiq made its largest bet ever by leading Anthropic’s $13 billion funding round in August at a $183 billion valuation, according to Matt Jacobson, a partner at Iconiq. He declined to ...

Some argue that the settlement — which has not yet been approved by the court — will fuel price hikes for generative AI models used in the enterprise. Anthropic has agreed to pay at least $1.5 billion ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

NIO Inc. (NYSE:NIO) shares fell sharply on Wednesday after the Chinese electric vehicle maker unveiled plans to raise fresh capital through a sizable equity offering. The company announced it will ...

The American Hospital Association is calling on federal regulators to launch an antitrust investigation into its claims of drug manufacturers’ actions regarding 340B rebate models. In a letter sent to ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...